Data from a human AR positive prostate cancer cell line, LNCaP, reveals that the set of AR and CHD1 interacting proteins overlap considerably, and CHD1-bound enhancer regions are highly concurrent with those bound by the AR (76). The gene discussed is CHD1; the disease is prostate cancer.